CFG
ABBV icon

Cambridge Financial Group’s AbbVie ABBV Stock Holding History

Cambridge Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.08M Buy
37,166
+355
+1% +$78.7K 3.02% 19
2025
Q4 		$8.41M Sell
36,811
-917
-2% -$209K 3.21% 14
2025
Q3 		$8.74M Buy
37,728
+10,431
+38% +$2.12M 3.39% 14
2025
Q2 		$5.07M Sell
27,297
-10,706
-28% -$1.99M 2.56% 25
2025
Q1 		$7.96M Sell
38,003
-300
-0.8% -$58.3K 3.46% 15
2024
Q4 		$6.81M Buy
+38,303
New +$7.04M 2.81% 24
2024
Q2 		$6.17M Buy
35,981
+2,255
+7% +$374K 2.77% 27
2024
Q1 		$6.14M Buy
33,726
+2,040
+6% +$352K 2.72% 27
2023
Q4 		$4.91M Sell
31,686
-2,634
-8% -$384K 2.46% 28
2023
Q3 		$5.12M Buy
+34,320
New +$5.04M 2.79% 24
2022
Q4 		$5.09M Sell
31,488
-2,085
-6% -$320K 2.84% 22
2022
Q3 		$4.51M Buy
+33,573
New +$4.82M 2.71% 23
2015
Q4 		– Sell
-90,488
Closed -$4.92M – 32
2015
Q3 		$4.92M Sell
90,488
-4,470
-5% -$291K 2.94% 25
2015
Q2 		$6.38M Buy
94,958
+779
+0.8% +$50.9K 3.4% 15
2015
Q1 		$5.51M Buy
94,179
+84,294
+853% +$5.09M 2.73% 30
2014
Q4 		$647K Buy
+9,885
New +$623K 3.15% 24

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cambridge Financial Group's ABBV Position: Q1 2026 in Review

Cambridge Financial Group increased its AbbVie (ABBV) stake by 0.96% in Q1 2026, buying an estimated $78.7K and bringing the position to 37,166 shares worth $8.08M. The position accounts for 3.02% of the portfolio, ranked #19.

Cambridge Financial Group first reported a position in ABBV in Q4 2014 and has held it in 16 quarters since. The position peaked at $8.74M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cambridge Financial Group held 37,166 shares of AbbVie worth $8.08M as of Q1 2026.
  • Cambridge Financial Group bought 355 AbbVie shares in Q1 2026, an estimated $78.7K.
  • AbbVie made up 3.02% of Cambridge Financial Group's portfolio in Q1 2026, its #19 holding.
  • Cambridge Financial Group first reported a position in AbbVie in Q4 2014 and has held it in 16 quarters since.
  • Cambridge Financial Group's AbbVie position peaked at $8.74M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cambridge Financial Group's 13F filing for Q1 2026, filed 14 May 2026.